The efficacy and safety of apremilast in patients with psoriatic arthritis concurrent with comorbidity in clinical practice

E. Yu. Loginova; Yu. L. Korsakova; A. D. Koltakova; E. E. Gubar; P. L. Karpova; S. I. Glukhova; T. V. Korotaeva

Rheumatology Science and Practice
Naučno-praktičeskaâ revmatologiâ

ISSN 1995-4484 (Print)
ISSN 1995-4492 (Online)

User

eng | рус

Rheumatology Science and Practice

Advanced search

Archives

Download this PDF file

Fullscreen

For citations:

Loginova E.Yu., Korsakova Yu.L., Koltakova A.D., Gubar E.E., Karpova P.L., Glukhova S.I., Korotaeva T.V. The efficacy and safety of apremilast in patients with psoriatic arthritis concurrent with comorbidity in clinical practice. Rheumatology Science and Practice. 2019;57(3):299-306. (In Russ.) https://doi.org/10.14412/1995-4484-2019-299-306

This work is licensed under a Creative Commons Attribution 4.0 License.

ISSN 1995-4484 (Print)
ISSN 1995-4492 (Online)

Username
Password
	Remember me
Not a user? Register with this site Forgot your password?

User

Rheumatology Science and Practice

For citations:

Cookies policy